Primary Site >> Colorectal Cancer

Gene >> CYP3A5

Journal: Mol Pharmacol. 1996 Feb;49(2):311-8.
Title: Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
Author: Schuetz, E G|Beck, W T|Schuetz, J D
PMID: 8632764
Journal: Mol Pharmacol. 1997 May;51(5):741-54.
Title: Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.
Author: Schmiedlin-Ren, P|Thummel, K E|Fisher, J M|Paine, M F|Lown, K S|Watkins, P B
PMID: 9145912
Journal: Mutat Res. 1997 May 12;376(1-2):153-60.
Title: The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies.
Author: Windmill, K F|McKinnon, R A|Zhu, X|Gaedigk, A|Grant, D M|McManus, M E
PMID: 9202751
Journal: Br J Cancer. 2002 Sep 9;87(6):681-6.
Title: Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
Author: Martinez, C|Garcia-Martin, E|Pizarro, R M|Garcia-Gamito, F J|Agundez, J A G
PMID: 12237780
Journal: Clin Cancer Res. 2005 May 15;11(10):3758-65.
Title: Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
Author: Kumarakulasingham, Meera|Rooney, Patrick H|Dundas, Sinclair R|Telfer, Colin|Melvin, William T|Curran, Stephanie|Murray, Graeme I
PMID: 15897573
Journal: Pharmacogenomics. 2006 Jun;7(4):575-85.
Title: Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8.
Author: Garcia-Martin, Elena|Pizarro, Rosa M|Martinez, Carmen|Gutierrez-Martin, Yolanda|Perez, Gabriela|Jover, Ramiro|Agundez, Jose Ag
PMID: 16753005
Journal: BMC Cancer. 2007 Jul 2;7:118.
Title: Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.
Author: Gervasini, Guillermo|Garcia-Martin, Elena|Ladero, Jose M|Pizarro, Rosa|Sastre, Javier|Martinez, Carmen|Garcia, Monserrat|Diaz-Rubio, Manuel|Agundez, Jose A G
PMID: 17605821
Journal: BMC Cancer. 2007 Jul 5;7:123.
Title: Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
Author: Bethke, Lara|Webb, Emily|Sellick, Gabrielle|Rudd, Matthew|Penegar, Stephen|Withey, Laura|Qureshi, Mobshra|Houlston, Richard
PMID: 17615053
Journal: Onkologie. 2007 Nov;30(11):559-63. Epub 2007 Nov 8.
Title: Genotyping of CYP3A5 polymorphisms among Bulgarian patients with sporadic colorectal cancer and controls.
Author: Petrova, Darinka Todorova|Yaramov, Nikolay|Toshev, Svetoslav|Nedeva, Petya|Maslyankov, Svilen|von Ahsen, Nicolas|Oellerich, Michael|Toncheva, Draga
PMID: 17992026
Journal: Mol Cancer. 2011 Jul 6;10:80.
Title: Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells.
Author: Basseville, Agnes|Preisser, Laurence|de Carne Trecesson, Sophie|Boisdron-Celle, Michele|Gamelin, Erick|Coqueret, Olivier|Morel, Alain
PMID: 21733184
Journal: Tumour Biol. 2013 Aug;34(4):2357-66.
Title: CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.
Author: Wang, Bao-Sheng|Liu, Zhen|Xu, Wei-Xue|Sun, Shao-Long
PMID: 23584898